Diligence memo · auto-generated · as of July 1, 2026
Novoflow
Novoflow: limited disclosed financing to assess.
Diligence furtherNo decisive signal either way from the public record alone — the call needs primary diligence beyond the filings.
Businessfiled
Novoflow operates in Healthtech, based in San Francisco, CA, USA. AI employees that automate medical operations for clinics.
Sub-sector tags: Healthcare, Healthcare Services, ai/ml, healthtech.
Capital & rounds (filed)filed
Novoflow has raised — in disclosed capital across 0 recorded rounds, aggregated from public filings.
Valuation (modeled)modeled
No modeled valuation — too little disclosed financing to estimate one.
Financing rhythm & timingmixed
Not enough dated financing history to read a financing rhythm.
Comparablesmixed
Capital scale ranks ahead of 8% of Healthtech peers (2138 compared).
Modeled value ranks above 8% of those peers.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.